$CRDL Might See Good Action - Announces Positive Topline Data $CRDL Finally comes out with impressive topline data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis. https://finance.yahoo.com/news/cardiol-therapeutics-announces-positive-topline-115800368.html We should see continuation of solid uptrend